EcoDrugPlus

Glutathione S-Transferase Pi 1

Ensembl ID : ENSSFOG00015002770
Gene Symbol: GSTP1
3 Cross references
160 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSSFOG00015014824
Gene Symbol: GSK3A
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSSFOG00015025489
Gene Symbol: LOC108920063
3 Cross references
221 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSSFOG00015011063
Gene Symbol: LOC108941853
3 Cross references
202 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSSFOG00015011715
Gene Symbol: LOC108920035
2 Cross references
995 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSSFOG00015030756
Gene Symbol: GHSR
3 Cross references
199 Possible Orthologues:

Growth Hormone-Releasing Hormone Receptor-Like

Ensembl ID : ENSSFOG00015001982
Gene Symbol: LOC108927482
2 Cross references
191 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSSFOG00015015137
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSSFOG00015030640
Gene Symbol: GUCY1A2
3 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSSFOG00015015091
Gene Symbol: GUCY1B1
1 Cross references
210 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSSFOG00015018365
Gene Symbol: HSP90AA1
3 Cross references
284 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSSFOG00015007867
Gene Symbol: HSP90AB1
1 Cross references
339 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).